Skip to main content

Cytokines 2026

External event
science conference on black background
Dates:
to
Location:
Glasgow, UK
Type:
In person
Find out more and register

The International Cytokine & Interferon Society (ICIS) invites you to attend Cytokines 2026, a leading international meeting dedicated to cytokine biology and its impact across medicine.

Taking place in Glasgow, a city with a long-standing history of medical innovation, this event will bring together researchers and clinicians from across the globe. Glasgow is home to world-leading medical research facilities, including Europe’s largest hospital and advanced centres for cancer care and precision medicine.

The meeting will feature a comprehensive scientific programme, including plenary and parallel sessions led by experts in the field. Poster sessions will provide valuable opportunities for in-depth discussion and knowledge exchange. A central aim of the conference is to foster collaboration between scientists and clinicians working in basic, translational and applied research.

Delegates will have the opportunity to present new findings and engage with the latest developments in cytokine research, including biomarkers and therapeutic approaches, while expanding their professional networks.

Find out more about the event and register here.

Local organising committee

  • Simon Jones, Cardiff University, UK (meeting co-chair)
  • Iain McInnes, University of Glasgow, UK (meeting co-chair)
  • Clare Bryant, University of Cambridge, UK
  • Clare Lloyd, Imperial College London, UK
  • Luke O’Neill, Trinity College Dublin, Ireland

Key dates

  • Abstract submission deadline: Friday 15 May 2026 (23:59 BST)
  • Abstract notifications: Mid-June 2026
  • Early-bird registration deadline: Friday 26 June 2026 (23:59 BST)
  • Standard registration deadline: Friday 25 September 2026 (23:59 BST)

About the organisers

The ICIS is a non-profit organisation of more than 1,200 scientists focused on cytokine, interferon and chemokine research. The society promotes interdisciplinary collaboration across cell biology, molecular biology, biochemistry and clinical research, supporting advances in treatments for autoimmune diseases, cancer, infectious diseases and inflammatory conditions.